RDCRN Contact Registry
The Rare Diseases Clinical Research Network (RDCRN) Contact Registry is an international patient contact registry sponsored by the National Institutes of Health. This registry collects basic data (i.e. contact information, diagnosis, medical history) to be stored in a secure, computerized database and used for the purpose of providing targeted information regarding a specific rare disease. Registrant information is not shared with anyone without the registrant’s permission and is stored in a secure, computerized database through the RDCRN’s Data Management and Coordinating Center (DMCC).
Function[edit | edit source]
The RDCRN contact registry is utilized by rare disease researchers to identify and recruit patients who are eligible for participation in future research studies.[1] The data is anonymously reported by patients or family members and they may also provide their contact information so that they may be notified in the case that the patient qualifies for participation in a research study. Additionally, patients receive updates on the progress of research projects in their rare disease of interest (such as site activations or protocol openings) from their rare disease consortium.
Funding[edit | edit source]
The RDCRN Contact Registry is operated by the Rare Diseases Clinical Research Network which is funded by the National Institutes of Health and the Office of Rare Diseases Research. It is governed by the RDCRN Steering Committee, which is advised by a network-wide Registry Advisory Committee. The advisory committee is composed of principal investigators from network consortia, representatives from patient advocacy and support groups affiliated with consortia, members of the Office of Rare Diseases Research, as well as members of RDCRN Data Management and Coordinating Center. The contact registry is designed, hosted, and maintained by the Health Informatics Institute at the University of South Florida.
References[edit | edit source]
- ↑ "Current Rare Disease Research". Retrieved 3 February 2012.
Additional Resources[edit | edit source]
- Richesson, R., Sutphen, R., Shereff, D., Krischer, J. (2011). The rare diseases clinical research network contact registry update: Features and functionality. Contemporary Clinical Trials. (In press.)
External links[edit | edit source]
Search WikiMD
Ad.Tired of being Overweight? Try W8MD's physician weight loss program.
Semaglutide (Ozempic / Wegovy and Tirzepatide (Mounjaro / Zepbound) available.
Advertise on WikiMD
WikiMD's Wellness Encyclopedia |
Let Food Be Thy Medicine Medicine Thy Food - Hippocrates |
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian
WikiMD is not a substitute for professional medical advice. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates Wikipedia, licensed under CC BY SA or similar.
Contributors: Prab R. Tumpati, MD